Chronic HCV infection: public health threat and emerging consensus. Vienna, Austria, October 27-28, 1995.
D000998:Antiviral Agents / Q000627:therapeutic use; D002908:Chronic Disease; D006526:Hepatitis C / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin